If you’re suffering from stabbing pain, numbness, tingling or a burning sensation in your arms, legs, hands or feet, you may ...

The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

Octavian Therapeutics ("Octavian" or "the Company"), a leading clinical-stage innovator in neuropathic pain treatment, today announces a transformative rebrand, the appointment of a new Non-Executive ...

Despite being one of the most effective cholesterol-lowering agents, statins remain a controversial topic in healthcare. This ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced additional follow-up ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Recently, we have been hearing buzz words like “medi-pedi” or “medical pedicure” but most people do not know what they mean ...

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...

Equities researchers at StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical ...

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...